Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer
Selecting a well-suited method for isolating/characterizing circulating tumor cells (CTCs) is challenging. Evaluating sensitive and specific markers for prostate cancer (PCa)-specific CTC identification and analysis is crucial. We used the CellCollector EpCAM-functionalized system (CC-EpCAM) and eva...
Main Authors: | Gerit Theil, Joanna Bialek, Christine Weiß, Felix Lindner, Paolo Fornara |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/2/497 |
Similar Items
-
Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
by: Gerit Theil, et al.
Published: (2021-07-01) -
Potential Use of CTCs as Biomarkers in Renal Cancer Patients
by: Joanna Bialek, et al.
Published: (2022-01-01) -
Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study
by: Hisamitsu Ide, et al.
Published: (2014-09-01) -
Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer
by: Tian Zhang, et al.
Published: (2021-02-01) -
Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management
by: Oscar Goodman, et al.
Published: (2014-03-01)